title: The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
authors.affiliation: Clinical Pharmacology Branch, National Cancer Institute, Bethesda, Maryland 20892.
authors.forename: C J
authors.initials: CJ
authors.lastname: Allegra
authors.forename: G F
authors.initials: GF
authors.lastname: Egan
authors.forename: J C
authors.initials: JC
authors.lastname: Drake
authors.forename: S M
authors.initials: SM
authors.lastname: Steinberg
authors.forename: S M
authors.initials: SM
authors.lastname: Swain
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors
chemical_list: D013940:Thymidylate Synthase; D002955:Leucovorin; D005472:Fluorouracil